Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction

Documenti analoghi

• Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
  di: Zhao, Qun, et al.
  Pubblicazione: (2015)
• The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction
  di: Zhang, Lixiang, et al.
  Pubblicazione: (2017)
• The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction
  di: Curtis, Nathan J, et al.
  Pubblicazione: (2014)
• Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
  di: Anderegg, M. C. J., et al.
  Pubblicazione: (2017)
• Minimally invasive abdominal and left thoracic approach for Siewert type II adenocarcinoma of the oesophagogastric junction: Novel technique for simultaneous combined use of laparoscopy and thoracoscopy
  di: Yuma Ebihara, et al.
  Pubblicazione: (2020-01-01)